Samenvatting
We describe a drug-drug interaction between coformulated lopinavir/ritonavir and itraconazole in a patient infected with human immunodeficiency virus type 1 who had disseminated histoplasmosis. Coadministration of these agents led to a strong increase in itraconazole concentrations and a decrease in concentrations of its metabolite, hydroxyitraconazole, which is equally active pharmacologically. The dosage of itraconazole was reduced when it was used in combination with lopinavir/ritonavir.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | e73-75 |
Tijdschrift | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Volume | 38 |
Nummer van het tijdschrift | 8 |
DOI's | |
Status | Gepubliceerd - 15 apr. 2004 |
Extern gepubliceerd | Ja |